Veracyte | VCYT - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Agenus USD 3.46M 6.08M 2025-09
Agilent USD 1.76B 31M 2025-12
Anika Therapeutics USD 57.48M 509K 2025-12
Arrowhead Research USD 201.64M 112.94M 2025-12
Bruker USD 293.1M 201.1M 2025-09
Exact Sciences USD 956M 166.96M 2025-12
Heron Therapeutics USD 43.07M 26.55M 2025-09
Illumina USD 1.42B 368M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Laboratory Of America USD 532.3M 65.8M 2025-12
Ligand Pharmaceuticals USD 174.93M 489.59M 2025-12
Myriad Genetics USD 149.6M 4.2M 2025-12
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Siemens EUR 14.5B 146M 2025-09
Sonic Healthcare AUD 645M 25.39M 2024-06
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Veracyte USD 362.58M 47M 2025-12
Waters USD 587.83M 128.71M 2025-12